Global Next Generation Sequencing Market 2015-2019

次世代シークエンシングの世界市場:次世代シークエンシング装置/試薬/消耗品

◆タイトル:Global Next Generation Sequencing Market 2015-2019
◆商品コード:IRTNTR5886
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年5月6日
◆ページ数:72
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名使用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、次世代シークエンシングの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、次世代シークエンシングの世界市場規模及び予測、技術別分析、製品別分析、需要先別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About NGS
Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized from a DNA template strand. The major difference is that NGS process is extended across millions of reactions in a massively parallel fashion, rather than restricted to a single or a few DNA fragments. This technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run. NGS finds application in whole genome, exome, and transcriptome sequencing that provide a high-resolution and global view of various applications such as the cancer genome. NGS coupled with bioinformatics tools has revolutionized cancer research, diagnosis, and therapy. This technology helps to track and trace the spread of disease and foreign contaminants in drugs.

Technavio’s analysts forecast the global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the global next generation sequencing market for the period 2015-2019. The global next generation sequencing market is divided into two segments: equipment, and reagents and consumables. To calculate the market size, the report considers the revenue generated from the sales of equipment, and reagents and consumables used in next generation sequencing in the following customer segments:
• Commercial entities such as hospitals and pharmaceutical and life sciences companies
• Research institutes

Technavio’s report, Global Next Generation Sequencing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Illumina
• Roche Diagnostics
• Thermo Fischer Scientific

[Other Prominent Vendors]
• 10X Genomics
• 23andMe
• Ambry Genetics
• Axeq Technologies
• Beijing Genomics Institute
• CLC bio
• Clontech Laboratories
• Fluidigm
• Foundation Medicine
• GATC Biotech
• GeneDx
• GENEWIZ
• Gnomegen
• Good Start Genetics
• Ingenuity Systems
• Knome
• NABsys
• Oxford Nanopore Technologies
• Pathogenica
• PerkinElmer
• RainDance Technologies
• Rubicon Genomics
• Sequenom
• Sigma-Aldrich
• Source Biosciences
• Takara Bio

[Market Driver]
• Increased Adoption by New Customers
• For a full, detailed list, view our report

[Market Challenge]
• Technical and Implementation Issues
• For a full, detailed list, view our report

[Market Trend]
• Strategic Alliances
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07.Genome Sequencing Cost Analysis

08.Cost of Equipment

09.Reimbursement and Coverage

10.Regulatory Point of View for NGS Tests
10.1 Analytical Performance of NGS Tests
10.2 Accessing Clinical Performance of NGS Tests
10.2.1 Leveraging Genetic Databases to Evaluate Clinical Performance
10.2.2 Communicate Information about Less Well-known Variants

11.Market Segmentation by Product
11.1 Global NGS Market by Product 2014-2019
11.2 Global NGS Market by Reagents and Consumables
11.2.1 Market Size and Forecast
11.3 Global NGS Market by Equipment
11.3.1 Market Size and Forecast

12.Market Segmentation by End-user
12.1 Global NGS Market by End-user 2014-2019

13.Market Segmentation by Technology
13.1 Global NGS Market by Technology
13.1.1 Sequencing by Synthesis
13.1.2 Ion Semiconductor Sequencing
13.1.3 Sequencing by Ligation
13.1.4 Pyrosequencing
13.1.5 SMRT Sequencing

14.Geographical Segmentation
14.1 Global NGS Market by Geographical Segmentation 2014-2019
14.2 NGS Market in Americas
14.2.1 Market Size and Forecast
14.3 NGS Market in EMEA
14.3.1 Market Size and Forecast
14.4 NGS Market in APAC
14.4.1 Market Size and Forecast

15.Buying Criteria

16.Market Growth Drivers

17.Drivers and their Impact

18.Market Challenges

19.Impact of Drivers and Challenges

20.Market Trends

21.Trends and their Impact

22.Vendor Landscape
22.1 Competitive Scenario
22.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2014
22.3 Other Prominent Vendors

23.Key Vendor Analysis
23.1 Illumina
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Business Segmentation
23.1.4 Geographical Segmentation by Revenue 2013
23.1.5 Business Strategy
23.1.6 Key Information
23.1.7 SWOT Analysis
23.2 Roche Diagnostics
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business Segmentation by Revenue 2013
23.2.4 Geographical Segmentation by Revenue 2013
23.2.5 Business Strategy
23.2.6 Key Developments
23.2.7 SWOT Analysis
23.3 Life Technologies now part of Thermo Fisher Scientific
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Business Segmentation by Revenue 2012
23.3.4 Geographical Segmentation by Revenue 2012
23.3.5 Business Strategy
23.3.6 Recent Developments
23.3.7 SWOT Analysis

24.Other Reports in this Series
List Of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global NGS Market 2014-2019 ($ million)
Exhibit 3: Cost per Genome 2001-2014 ($ million)
Exhibit 4: Cost per Megabase of DNA Sequence 2001-2014 ($)
Exhibit 5: Estimated Cost of NGS Equipment
Exhibit 6: Global NGS Market by Product 2014
Exhibit 7: Global NGS Market by Product 2019
Exhibit 8: Global NGS Market by Product 2014-2019
Exhibit 9: Global NGS Market by Reagents and Consumables 2014-2019 ($ million)
Exhibit 10: Global NGS Market by Equipment 2014-2019 ($ million)
Exhibit 11: Global NGS Market by End-user 2014
Exhibit 12: Global NGS Market by Geographical Segmentation 2014
Exhibit 13: Global NGS Market by Geographical Segmentation 2019
Exhibit 14: Global NGS Market by Geographical Segmentation 2014-2019
Exhibit 15: NGS Market in Americas 2014-2019 ($ million)
Exhibit 16: NGS Market in EMEA 2014-2019 ($ million)
Exhibit 17: NGS Market in APAC 2014-2019 ($ million)
Exhibit 18: Market Share Analysis 2014
Exhibit 19: Illumina: Business Segmentation
Exhibit 20: Illumina: Geographical Segmentation by Revenue 2013
Exhibit 21: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 22: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Exhibit 23: Life Technologies: Business Segmentation by Revenue 2012
Exhibit 24: Life Technologies: Geographical Segmentation by Revenue 2012



【掲載企業】

Illumina, Roche Diagnostics, Thermo Fischer Scientific, 10X Genomic, 23andMe, Ambry Genetics, Axeq Technologies, Beijing Genomics Institute, CLC bio, Clontech Laboratories, Fluidigm, Foundation Medicine, GATC Biotech, GeneDx, GENEWIZ, Gnomegen, Good Start Genetics, Ingenuity Systems, Knome, NABsys, Oxford Nanopore Technologies, Pathogenica, PerkinElmer, RainDance Technologies, Rubicon Genomics, Sequenom, Sigma-Aldrich, Source Biosciences, Takara Bio

【資料のキーワード】

次世代シークエンシング技術、DNAシークエンシング、次世代シークエンシング装置、次世代シークエンシング試薬、次世代シークエンシング消耗品

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[次世代シークエンシングの世界市場:次世代シークエンシング装置/試薬/消耗品] (Global Next Generation Sequencing Market 2015-2019 / IRTNTR5886)販売に関する免責事項
[次世代シークエンシングの世界市場:次世代シークエンシング装置/試薬/消耗品] (Global Next Generation Sequencing Market 2015-2019 / IRTNTR5886)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆